Ex Parte Moriyama et al - Page 3

                 Appeal 2007-1855                                                                                                        
                 Application 10/815,650                                                                                                  
                 claims 7 and 8 under 35 U.S.C. § 103(a) as unpatentable over Machida                                                    
                 evidenced by Grant, Appellants’ disclosure in the Specification at page 3,                                              
                 lines 10-16; page 11, line 23, to page 12, line 1; and Table 1, and Nanya (id.                                          
                 13-15).                                                                                                                 
                        Appellants argue the grounds of rejection as a whole based on the                                                
                 limitations in claim 1 (Br. in entirety).  Thus, we decide this appeal based on                                         
                 claim 1.  37 C.F.R. § 41.37(c)(1)(vii) (2005).                                                                          
                        The Examiner finds Machida discloses toner compositions falling                                                  
                 within appealed claim 1 which includes an activated carbon with “the trade                                              
                 name ‘Shirawashi A-1’ obtained from Takeda Pharmaceutical Industries                                                    
                 K.K.,” that has “an average particle diameter of 4.5 µm . . . within the                                                
                 numerical value of the particle size range of ‘5.6 µm or less’” specified in                                            
                 claim 1 (Answer 6, citing Machida 8 and Table 3).  With respect to                                                      
                 Appellant Moriyama’s testimony2 that “[t]he commercial product described                                                
                 in the English translation of [Machida] . . . . is actually . . . “Shirasagi A-1”                                       
                 now “obtained from the manufacturer (Japan EnviroChemicals, Ltd.”                                                       
                 (Moriyama Declaration ¶¶ 3 and 6), the Examiner contends “there is no                                                   
                 reason to think that the actual name or source makes a difference” (Answer                                              
                 16).  The Examiner finds Grant evinces activated carbon is charcoal as                                                  
                 specified in claim 1 (id. 7-8).                                                                                         
                        The Examiner finds Machida does not disclose the “4.5 µm average                                                 
                 particle size” is a volume-based median particle size with a coefficient of                                             
                 variation (CV) of 80% or less as specified in claim 1 (Answer 8).  The                                                  
                 Examiner finds Machida discloses “toner (1)” with 4.5 µm average particle                                               

                                                                                                                                        
                 2  Appellants submitted the Declaration Under 37 C.F.R. 1.132 of Appellant                                              
                 Shinji Moriyama (Moriyama Declaration) on October 27, 2005 and rely                                                     
                 thereon herein (Br., e.g., 4-5 and Evidence Appendix).                                                                  
                                                          3                                                                              









Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next

Last modified: September 9, 2013